Faculty Opinions recommendation of A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3.
2019 ◽
Vol 48
(7)
◽
pp. 917-923
◽
2010 ◽
Vol 128
(3)
◽
pp. 289
◽
2017 ◽
Vol 43
(3)
◽
pp. 362-367
◽
2020 ◽
2019 ◽